Carpal Tunnel Syndrome (CTS) remains an elusive, unsolved medical problem. Current mainstream approaches address the problem at the site of symptoms, but this approach only partially accounts for the causes and effects of CTS. Growing evidence suggests that CTS impacts not only the nervous system at the hand, but also impacts the brain.
A team at the U of A and Banner Health is looking for people who have been diagnosed with Type 2 diabetes to join a study about a new approach to managing your blood sugar.
The study will last about 1 month and will take place at a UA/Banner Health outpatient clinic near BUMC-Tucson South. You will attend an individual education session and receive information that might help you lose weight.
Completion of the proposed studies will correlate the specific genes, proteins, nucleic acids or bacterial species with gastrointestinal, pancreato-biliary and hepatology disorders, including but not limited to cancer. A secondary point will be to determine whether specific biomarkers found in bodily fluids or tissue predict qualitative and quantitative changes in metabolic pathways.
A research team at the U of A is looking for people who have been diagnosed with Type 2 diabetes to join a study about a new mobile application being designed to help people manage Type 2 diabetes.
We will ask you to review different ways to track your diet and give us your opinions about them. If you join the study, you will attend a one-time in-person visit with the researchers at a UA facility near BUMC South.
The study aims to assess the safety and efficacy of Viaskin Peanut to induce desensitization to peanut in peanut-allergic children 1 to 3 years of age after a 12-month treatment by EPicutaneous ImmunoTherapy (EPIT)
Your child is invited to participate because your child has a peanut allergy. The study will last up to 72 weeks where you will take daily study drug, monthly study injections, complete study questionnaires/diaries, food challenge, skin prick tests, breathing tests, and have your blood drawn.
For Dupilumab there are common risks such as: conjunctivitis (pink eye), injection site reaction (swelling, redness, etc.), your child may experience a local or generalized allergic reaction (also known as a hypersensitivity reaction).
As people get older, the immune system can become less effective at dealing with infectious diseases. This decreased immune function can be highly variable from person to person, and at different ages in life. Many people carry a virus (called cytomegalovirus) for their whole life – this virus causes no symptoms in most people, but may influence how their immune system works as they get older. This process of “immune aging” may happen more quickly in people with HIV infection.